))
Aurrigo's 160% Surge, Oxford Drug Design Funding, Fossil-Free Fuel at National Oceanography Centre
Manage episode 442961240 series 3522529
The Business Magazine에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 The Business Magazine 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
These are the top stories making the headlines across The Business Magazine website today:
Aurrigo International sees strong growth in autonomous division in first half
Coventry-based Aurrigo International plc reported a significant first-half growth in its autonomous ground handling technology division, achieving £800,000 in revenue—a 160% increase— and projecting annual sales to reach £3 million.
Full story here: https://thebusinessmagazine.co.uk/companies/aurrigo-international-sees-strong-growth-in-autonomous-division-in-first-half/
Oxford Drug Design set to help advance new treatments for CF lung infections
Oxford Drug Design has received £466,000 from the Cystic Fibrosis Antimicrobial Resistance Syndicate’s £3 million Collaborative Discovery Programme, funded by LifeArc, to develop new treatments targeting bacterial infections in Cystic Fibrosis patients using AI technology.
Full story here: https://thebusinessmagazine.co.uk/companies/oxford-drug-design-set-to-help-advance-new-treatments-for-cf-lung-infections/
Southampton’s National Oceanography Centre trials low-carbon fuel
On World Maritime Day, Southampton’s National Oceanography Centre marked the occasion by successfully trialing fossil-free marine diesel made from hydrotreated vegetable oil (HVO) on two of its Royal Research Ships, James Cook and Discovery.
Full story here: https://thebusinessmagazine.co.uk/esg/southamptons-national-oceanography-centre-trials-low-carbon-fuel/
257 에피소드
공유
